降低LDLC是降低心血管事件基石精品.ppt

降低LDL-C是降低事件的基石  内容 冠心病与LDL-C的关 冠心病与 ASCVD的关亲 ASCVD与LDLC的关条 冠心病患者LDLC降低目标 中国冠 者目前 现状? 何提高 他汀降低冠心病患者LDLC的临床疗效及妾全性(4  ASCⅴD作为与死亡密切相关的疾病逐渐被患者认识 Merriam- Dictionar 韦氏医学网络辞典网站 ascvd 上患者对 ASCVD的提问 ASCVD I ina Martin Columbia High School Columba, South Carolina (Final diseass af condition result ing in death 我姐姐的死亡证明 Reply Lke- 20 hours ago Brenda Joy ce Conkle-Whetzel- John Marshall High School, Gler ,我丈夫的死亡证明 ON MY HUSBANDS DEATH CERTIFICATE WENDY KELLEY IS OUR DAUGHT NoTFAT Linda C Stultz Unversity of Phoe 我父亲的死亡证明 listed thers death certificat Lke.F ttp///medical/ascvd  动脉粥样硬化性心血管疾病( ASCVD):新热点1.2 “2013年ⅠAS建议”和”2014美国国家脂质协会血脂异常管理建议”均紧紧围绕 动脉桦硬化性心血管疾病( ASCVD)”这一主题 INTERNATIONAL An International Atherosclerosis Society Position Pap ATHEROSCLEROSIS Global recommendations for the Management of Dyslipidemia 2013国际动脉粥样硬化学会(IAS)立场报告:全球血脂异常诊治建议1 na National Lipid Association recommendations for patient-centered management of dyslipidemia Part 1-executive summary 2014美国国家脂质协会血脂异常管理建议2 L._/download/iaspp_guidelinesExsummarYpdf  2013年IAS建议 冠心病患者是 ASCVD的二级预防人群 ATHERSSCLEROSIS2013国际动脉粥样硬化学会(IAS)立场报告:全球血脂异常诊治建议 Secondary prevention extends to all patients with established ASCVD. These conditions include a history of CHD, stroke, peripheral arterial disease, carotid artery disease, and other forms of atherosclerotic vascular disease ASCVD二级预防包合 1. CHD 2.卒中 3.外周动脉疾病、頸动脉疾病和其他动脉粥枰硬化血管疾病 ASCVD为全身性 相同,上游预防措施相同。  体内LDL水平增加是导致 动脉粥样硬化形成以及 ASCVD发生的必要条件1 hAA2013国际动脉粥样硬化学会(IAS)立场报告:全球血脂异常诊治建议 ATHEROSCLEROSIS Pathogenesis of atherosclerosis. Some elevation of LDL seemingly is required for atherogenesis and hence ASCVD(NCEP 2002: De Backer et al. 2003; Genest et al. 2003) LDL accounts for more than 75% of atherogenic lipoproteins, the others being cholesterol enriched remnants of triglyceride-rich lipoproteins. The latter play a larger role when triglycerides are elevated. When LDL infiltrates into the arterial wall, it i